A well-designed information leaflet has the potential to raise immediate knowledge levels of oral cancer in patients attending primary care facilities. Anxiety about an oral health screen appears not ...

The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2.5mg ...

Bayer and Janssen’s novel oral anticoagulant (NOAC) Xarelto has a new string to its bow after the FDA approved it to prevent blood clots in acutely ill medical patients. The drug, marketed by Johnson ...

Michael Boyle is an experienced financial professional with more than 10 years working with financial planning, derivatives, equities, fixed income, project management, and analytics. Asymmetric ...

The G7 Cybersecurity Working Group releases new SBOM for AI guidance, outlining seven key data clusters to boost transparency and security across AI supply chains ...